A recent study highlights the successful use of growth hormone (GH) treatment for hepatopulmonary syndrome in patients with panhypopituitarism-related advanced liver disease. This research could pave the way for new therapeutic approaches in managing this complex condition.
successful gh treatment of hepatopulmonary syndrome in panhypopituitarism related advanced liver disease
Original title: “Successful GH Treatment of Hepatopulmonary Syndrome in Panhypopituitarism-related Advanced Liver Disease.”